Ramin Massoumi
11 – 20 of 80
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
High expression of CD34 and α6-integrin contributes to the cancer-initiating cell behaviour in ultraviolet-induced mouse skin squamous cell carcinoma
(
- Contribution to journal › Article
-
Mark
Preferential Killing of Tetraploid Colon Cancer Cells by Targeting the Mitotic Kinase PLK1
(
- Contribution to journal › Article
-
Mark
Inhibition of mitotic kinase Mps1 promotes cell death in neuroblastoma
(
- Contribution to journal › Article
-
Mark
Discovery of epi-enprioline as a novel drug for the treatment of vincristine resistant neuroblastoma
(
- Contribution to journal › Article
-
Mark
Gene expression signature of acquired chemoresistance in neuroblastoma cells
(
- Contribution to journal › Article
-
Mark
CYLD, a mechanosensitive deubiquitinase, regulates TGFβ signaling in load-induced bone formation
(
- Contribution to journal › Article
- 2019
-
Mark
Decreased expression of nemo-like kinase in melanoma is correlated with increased vascularity and metastasis
(
- Contribution to journal › Article
-
Mark
Cyclophilin Inhibitor NV556 Reduces Fibrosis and Hepatocellular Carcinoma Development in Mice With Non-Alcoholic Steatohepatitis
(
- Contribution to journal › Article
-
Mark
Evaluation of NV556, a Novel Cyclophilin Inhibitor, as a Potential Antifibrotic Compound for Liver Fibrosis
(
- Contribution to journal › Article
- 2018
-
Mark
Reversine inhibits Colon Carcinoma Cell Migration by Targeting JNK1
(
- Contribution to journal › Article